Beijing Tiantan Biological Products Co., Ltd.

¥12.67As of Sun 8 Nov 2026, 12:00 UTC
SSE:600161Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 1.44%
Div yield 1.58%
ROE 6.32%
Biotechnology
Beta (5Y) 0.24
PE TTM 35.19
TSR TTM (30.42%)
Mkt cap ¥25.05B
ROIC 6.91%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥14
8.81%
(17.66%)
Hold 7|12|1|0|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.20
0.21
0.21
0.24
24.25%
24.13%
25.51%
30.27%
Revenue¥B
1.762
1.817
1.771
1.793
12.88%
13.17%
6.32%
1.73%
Peers (US$3.756B)
Cap (US$)
PE
4.058B
—
3.409B
26.88x
Capital
TTM
5Y
10Y
Leveragex
1.371
0.024
0.022
EBIT/Intx
1.807
0.101
0.120
Own earn%
(98.15)
(9.62)
(9.22)
Sh yield%
15.11
32.96
32.81
Owners
Insiders/Inst%
12.93
36.16
Short interest%
2.24
SBC / revenue%
1.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
20–25
$1 testx
—
Incr. ROIC%
40